Corbevax: India’s 1st indigenously RBD protein sub-unit vaccine against COVID-19 is now the country’s 3rd Indigenously Developed Vaccine
Molnupiravir is an antiviral that inhibits SARS-CoV-2 replication by viral mutagenesis.
Molnupiravir is an antiviral that inhibits SARS-CoV-2 replication by viral mutagenesis.